JP2024540303A5 - - Google Patents

Info

Publication number
JP2024540303A5
JP2024540303A5 JP2024526614A JP2024526614A JP2024540303A5 JP 2024540303 A5 JP2024540303 A5 JP 2024540303A5 JP 2024526614 A JP2024526614 A JP 2024526614A JP 2024526614 A JP2024526614 A JP 2024526614A JP 2024540303 A5 JP2024540303 A5 JP 2024540303A5
Authority
JP
Japan
Prior art keywords
compound
solid
formula
solvate
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526614A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540303A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079221 external-priority patent/WO2023081757A1/en
Publication of JP2024540303A publication Critical patent/JP2024540303A/ja
Publication of JP2024540303A5 publication Critical patent/JP2024540303A5/ja
Pending legal-status Critical Current

Links

JP2024526614A 2021-11-03 2022-11-03 Pi3k-アルファ阻害剤、その調製方法及び使用方法 Pending JP2024540303A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163263474P 2021-11-03 2021-11-03
CNPCT/CN2021/128533 2021-11-03
US63/263,474 2021-11-03
CN2021128533 2021-11-03
PCT/US2022/079221 WO2023081757A1 (en) 2021-11-03 2022-11-03 Pi3k-alpha inhibitors and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2024540303A JP2024540303A (ja) 2024-10-31
JP2024540303A5 true JP2024540303A5 (https=) 2025-11-06

Family

ID=86242193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526614A Pending JP2024540303A (ja) 2021-11-03 2022-11-03 Pi3k-アルファ阻害剤、その調製方法及び使用方法

Country Status (12)

Country Link
EP (1) EP4426314A4 (https=)
JP (1) JP2024540303A (https=)
KR (1) KR20240112283A (https=)
CN (1) CN118401245A (https=)
AU (1) AU2022381187A1 (https=)
CA (1) CA3236861A1 (https=)
CL (1) CL2024001364A1 (https=)
IL (1) IL312466A (https=)
MX (1) MX2024005429A (https=)
PE (1) PE20250676A1 (https=)
TW (1) TW202334136A (https=)
WO (1) WO2023081757A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4143196A4 (en) 2020-04-29 2024-04-17 Relay Therapeutics, Inc. PI3K-A INHIBITORS AND METHODS OF USE THEREOF
WO2024055992A1 (zh) * 2022-09-14 2024-03-21 南京再明医药有限公司 三环化合物及其应用
TW202541794A (zh) 2022-11-02 2025-11-01 美商佩特拉製藥公司 用於治療疾病之磷酸肌醇3-激酶(pi3k)之靶向別位及正位袋點
KR20260005985A (ko) 2023-05-05 2026-01-12 일라이 릴리 앤드 캄파니 Er+ 유방암을 갖는 대상체에서 중추 신경계 (cns) 전이를 치료 및 예방하는 데 사용하기 위한 임루네스트란트 또는 그의 염

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010007100A1 (en) * 2008-07-15 2010-01-21 Cellzome Ltd 7-substituted amino triazoles as pi3k inhibitors
PE20161323A1 (es) * 2013-09-05 2016-11-25 Hoffmann La Roche Compuestos de triazolopiridina, composiciones y metodos de uso de los mismos
WO2017000277A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Substituted triazolo bicycliccompounds as pde2 inhibitors
WO2020173935A1 (en) * 2019-02-26 2020-09-03 Boehringer Ingelheim International Gmbh New isoindolinone substituted indoles and derivatives as ras inhibitors
EP4143196A4 (en) * 2020-04-29 2024-04-17 Relay Therapeutics, Inc. PI3K-A INHIBITORS AND METHODS OF USE THEREOF

Similar Documents

Publication Publication Date Title
JP2024540303A5 (https=)
JP4353542B2 (ja) Hivプロテアーゼ阻害剤を含有する医薬組成物
RU2731179C2 (ru) Фенфлураминовые композиции и способы их получения
RU2213743C2 (ru) Производное тиенилазолилалкоксиэтанамина, способ его получения (варианты), фармацевтическая композиция, промежуточный продукт и способ его получения (варианты)
FR2823209A1 (fr) Nouvelles thiohydantoines et leur utilisation en therapeutique
JPH08501095A (ja) 置換チアゾリジンジオン誘導体
MXPA03011448A (es) Derivados de n-arilfenilacetamida y composicion farmaceutica que los contienen.
JP2001523712A (ja) Pde−ivのベンゼンスルホンアミド阻害剤およびそれらの治療的使用
JP2010540638A (ja) セラミド誘導体を用いる多発性嚢胞腎疾患の治療方法
US7879886B2 (en) Iron binding agents
JP2009530401A (ja) フェノールヒドラゾンマクロファージ転移阻害因子阻害剤
JP5179190B2 (ja) 神経変性疾病の治療において1,4−ビス(3−アミノアルキル)ピペラジン誘導体を使用する方法
HU179170B (en) Process for producing phenethanolamine derivatives
JP5833143B2 (ja) フェニル−イソオキサゾール誘導体およびその製造方法
KR20200131382A (ko) 펠루비프로펜의 신규 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
JP2005529933A (ja) キサンチンホスホジエステラーゼvインヒビター多形体
CN111954663A (zh) 氟化的4-(取代的氨基)苯基氨基甲酸酯衍生物
US11571416B2 (en) Amodiaquine analogs and methods of uses thereof
CN1642926A (zh) 结晶帕瑞考昔钠
JPH07500604A (ja) 高血圧治療用エチルアラニンアミノジオール化合物
JPWO1994001392A1 (ja) (−)−リトドリン
TW200418792A (en) Amino acid phenoxy ethers
US20110269838A1 (en) Novel processes and pure polymorphs
JP3891503B2 (ja) 製薬学的に活性なβ−アミノ酸類の許容性の改善
JP2017514841A (ja) 多形形態の[5−フルオロ−3−({2−[(4−フルオロベンゼン)スルホニル]ピリジン−3−イル}メチル)−2−メチルインドール−1−イル]−酢酸